HHS and PhRMA will continue to pause a lawsuit challenging the government's 340B ADR process.

PhRMA, HHS Seek Continued Pause on 340B ADR Lawsuit

A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.